The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2,4-diamino-6-[(3,4-di-chlorobenzyl)nitrosamino]quinazoline acetate ID: ALA3272735
PubChem CID: 90677671
Max Phase: Preclinical
Molecular Formula: C17H16Cl2N6O3
Molecular Weight: 363.21
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)O.Nc1nc(N)c2cc(N(Cc3ccc(Cl)c(Cl)c3)N=O)ccc2n1
Standard InChI: InChI=1S/C15H12Cl2N6O.C2H4O2/c16-11-3-1-8(5-12(11)17)7-23(22-24)9-2-4-13-10(6-9)14(18)21-15(19)20-13;1-2(3)4/h1-6H,7H2,(H4,18,19,20,21);1H3,(H,3,4)
Standard InChI Key: CRQQJZKCLNMADH-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
22.6367 -5.9998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3512 -5.5873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0657 -5.9998 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.3512 -4.7623 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4854 -2.7498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4843 -3.5772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1990 -3.9900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1972 -2.3371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9127 -2.7462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9134 -3.5730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6287 -3.9840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3437 -3.5693 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.3389 -2.7393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6231 -2.3321 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.0508 -2.3225 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.6304 -4.8090 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.7696 -3.9891 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.0554 -3.5760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3406 -3.9880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6273 -3.5727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9130 -3.9840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9119 -4.8099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6310 -5.2228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3424 -4.8092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1995 -5.2206 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
16.6333 -6.0435 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
18.7689 -4.8141 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.0541 -5.2260 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 2 0
5 6 2 0
6 7 1 0
7 10 2 0
9 8 2 0
8 5 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
13 15 1 0
11 16 1 0
6 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
22 25 1 0
23 26 1 0
17 27 1 0
27 28 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 363.21Molecular Weight (Monoisotopic): 362.0450AlogP: 3.79#Rotatable Bonds: 4Polar Surface Area: 110.49Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.87CX LogP: 3.70CX LogD: 3.59Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.54Np Likeness Score: -1.22
References 1. Elslager EF, Jacob P, Johnson J, Werbel LM, Worth DF, Rane L.. (1978) Folate antagonists. 13. 2,4-Diamino-6-](alpha,alpha,alpha-trifluoro-m-tolyl)thio]quinazoline and related 2,4-diamino-6-[(phenyl- and naphthyl)thio]quinazolines, a unique class of antimetabolites with extraordinary antimalarial and antibacterial effects., 21 (10): [PMID:102792 ] [10.1021/jm00208a010 ]